Amrutanjan Health Care Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 10.60% vs 6.57% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 6.65% vs 11.13% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 44.35% vs 9.06% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 25.00% vs -20.00% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Amrutanjan Healt With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

149.77

126.33

23.44

18.55%

Other Operating Income

0.00

Total Operating income

149.77

126.33

23.44

18.55%

Raw Material Cost

31.30

63.99

-32.69

-51.09%

Purchase of Finished goods

40.98

0.00

40.98

(Increase) / Decrease In Stocks

1.24

-2.48

3.72

150.00%

Employee Cost

15.65

15.72

-0.07

-0.45%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

17.58

0.00

17.58

Other Expenses

17.47

29.01

-11.54

-39.78%

Total Expenditure (Excl Depreciation)

124.22

106.24

17.98

16.92%

Operating Profit (PBDIT) excl Other Income

25.55

20.09

5.46

27.18%

Other Income

4.73

4.69

0.04

0.85%

Operating Profit (PBDIT)

30.28

24.78

5.50

22.20%

Interest

0.05

1.06

-1.01

-95.28%

Exceptional Items

-7.61

0.00

-7.61

Gross Profit (PBDT)

22.62

23.72

-1.10

-4.64%

Depreciation

1.61

4.35

-2.74

-62.99%

Profit Before Tax

21.02

19.37

1.65

8.52%

Tax

4.82

4.64

0.18

3.88%

Provisions and contingencies

0.00

Profit After Tax

16.19

14.74

1.45

9.84%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

16.19

14.74

1.45

9.84%

Equity Capital

2.89

3.09

-0.20

-6.47%

Face Value

1.00

5.00

0.00

Reserves

0.00

Earnings per share (EPS)

5.60

23.85

-18.25

-76.52%

Diluted Earnings per share

5.60

23.85

-18.25

-76.52%

Operating Profit Margin (Excl OI)

17.06%

15.90%

0.00

1.16%

Gross Profit Margin

15.10%

18.78%

0.00

-3.68%

PAT Margin

10.81%

11.67%

0.00

-0.86%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 149.77 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 6.19% vs 19.83% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 10.60% vs 6.57% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 16.19 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -16.76% vs 39.33% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.65% vs 11.13% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 25.55 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 1.51% vs 52.27% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 44.35% vs 9.06% in Mar 2025

Quarterly - Interest

Interest 0.05 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 25.00% vs -20.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 17.06%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025